Home→Courses→Regulatory Strategy for Combination Products Training Course
Biotechnology and Pharmaceutical Development
Regulatory Strategy for Combination Products Training Course
Introduction
Regulatory Strategy for Combination Products Training Course is designed to provide professionals with a comprehensive understanding of the complex regulatory framework surrounding combination products. With the increasing integration of drug, device, and biologic technologies, navigating the regulatory requirements set by agencies like the FDA and EMA has become crucial for compliance and successful product approval. This course equips participants with the necessary tools to design and implement effective regulatory strategies for these hybrid products, ensuring that they meet safety, efficacy, and quality standards while optimizing market entry and lifecycle management.
As the combination products sector continues to grow, understanding how to address regulatory challenges and streamline approval processes is essential for companies looking to maintain a competitive edge. This training focuses on the key aspects of combination product regulations, including classification, design controls, premarket approval, post-market surveillance, and risk management. Through a combination of theoretical knowledge and practical case studies, participants will gain the expertise to manage regulatory affairs efficiently, mitigate risks, and drive compliance across the product lifecycle.
Programme Curriculum
Regulatory Strategy for Combination Products Training Course
Introduction
Regulatory Strategy for Combination Products Training Course is designed to provide professionals with a comprehensive understanding of the complex regulatory framework surrounding combination products. With the increasing integration of drug, device, and biologic technologies, navigating the regulatory requirements set by agencies like the FDA and EMA has become crucial for compliance and successful product approval. This course equips participants with the necessary tools to design and implement effective regulatory strategies for these hybrid products, ensuring that they meet safety, efficacy, and quality standards while optimizing market entry and lifecycle management.
As the combination products sector continues to grow, understanding how to address regulatory challenges and streamline approval processes is essential for companies looking to maintain a competitive edge. This training focuses on the key aspects of combination product regulations, including classification, design controls, premarket approval, post-market surveillance, and risk management. Through a combination of theoretical knowledge and practical case studies, participants will gain the expertise to manage regulatory affairs efficiently, mitigate risks, and drive compliance across the product lifecycle.
Course Duration
10 days
Course Objectives
Understand the regulatory landscape for combination products across global markets.
Identify the classification systems for combination products and their regulatory requirements.
Analyze FDA and EMA guidelines for combination product approval and lifecycle management.
Navigate the complexities of premarket approval pathways, including NDA, PMA, and BLA.
Learn about risk management practices and strategies in the development of combination products.
Develop strategies for maintaining compliance with post-market surveillance regulations.
Master the submission requirements for combination products, including IND, IDE, and NDA submissions.
Examine labeling and advertising requirements for combination products under global regulations.
Understand the challenges of integrating drug and device components in combination products.
Leverage digital health technologies and software as part of regulatory submissions.
Explore key strategies for dealing with regulatory inspections and audits.
Gain insights into the regulatory impact of combination products on clinical trials and patient outcomes.
Build practical regulatory strategies for the commercialization of combination products.
Target Audience
Regulatory Affairs Professionals
Product Development Teams
Compliance Managers in Pharmaceutical and Medical Device Companies
Clinical Research Professionals
Quality Control and Assurance Managers
Legal Advisors in the Life Sciences Industry
Senior Executives in Pharmaceutical Companies
Entrepreneurs and Innovators in Healthcare Technology
Course Modules
Module 1: Introduction to Combination Products
Definition of combination products
Types of combination products
Case study: Regulatory bodies and their role (FDA, EMA)
Importance of understanding regulations
Overview of global regulatory differences
Module 2: Regulatory Classification of Combination Products
FDA classification criteria
Classification under the EU Medical Devices Directive
Hybrid products and their regulatory impact
Combination product categories
Case study: Regulatory classification challenges
Module 3: Premarket Approval Strategies
Premarket approval (PMA) vs NDA vs BLA
Regulatory submission requirements
Importance of early regulatory strategy planning
Key elements of a successful premarket approval application
Case study: Accelerated approval process
Module 4: Risk Management in Combination Products
Identifying risks in combination product development
Implementing risk management frameworks
Risk assessment tools
Post-market risk management
Case study: Effective risk mitigation in product development
Module 5: Post-Market Surveillance and Compliance
FDAΓÇÖs post-market surveillance requirements
Managing adverse event reporting
Monitoring product safety post-launch
Managing recalls and corrective actions
Case study: Real-world post-market surveillance challenges
Module 6: Labeling and Advertising Regulations
Labeling requirements for combination products
Global advertising and marketing compliance
FDA vs EMA labeling guidelines
Misbranding and enforcement actions
Case study: Labeling issues in combination products
Module 7: Clinical Trials for Combination Products
Designing clinical trials for hybrid products
Regulatory approval for combination product trials
Compliance with GxP regulations
Handling adverse event reporting during trials
Case study: Clinical trial delays in combination products
Module 8: Quality Management Systems (QMS)
ISO 13485 and GMP requirements for combination products
Implementing QMS in product development
Audits and inspections
Continuous improvement processes
Case study: QMS failures and product recalls
Module 9: Navigating Regulatory Inspections
Understanding FDA inspections for combination products
Preparing for international inspections
Common inspection findings and how to address them
Inspection readiness best practices
Case study: Handling an FDA audit
Module 10: Digital Health Technologies and Regulations
Regulatory considerations for software and mobile applications
FDA guidelines for digital health products
Incorporating digital health technologies in combination products
Risk and privacy considerations
Case study: FDAΓÇÖs stance on digital health technology
Module 11: Global Regulatory Considerations
Understanding regional regulatory differences
Navigating the approval process in emerging markets
Regulatory harmonization initiatives
Case study: Regulatory challenges in Asia-Pacific
Market entry strategies for international markets
Module 12: Advanced Regulatory Strategies
Strategies for fast-track approvals
Dealing with regulatory uncertainties
Planning for post-approval changes
Impact of evolving regulatory frameworks
Case study: Managing complex regulatory scenarios
Module 13: Strategic Market Access for Combination Products
Understanding reimbursement and pricing
Market access considerations across global markets
Regulatory impact on market entry strategy
Partnerships and collaborations in the market
Case study: Access strategy for combination products in Europe
Module 14: Product Lifecycle Management
Managing combination product lifecycle
Regulatory considerations through the product lifecycle
Planning for post-market modifications and updates
Developing global lifecycle management strategies
Case study: Lifecycle management of a successful combination product
Module 15: Preparing for the Future: Regulatory Innovations
The future of combination products regulations
Emerging regulatory trends
Impact of artificial intelligence on regulatory strategy
The role of real-world evidence in regulatory approvals
Case study: Predicting future regulatory challenges
Training Methodology
This course employs a participatory and hands-on approach to ensure practical learning, including:
Interactive lectures and presentations.
Group discussions and brainstorming sessions.
Hands-on exercises using real-world datasets.
Role-playing and scenario-based simulations.
Analysis of case studies to bridge theory and practice.
Peer-to-peer learning and networking.
Expert-led Q&A sessions.
Continuous feedback and personalized guidance.
Register as a group from 3 participants for a Discount
Upon successful completion of this training, participants will be issued with a globally- recognized certificate.
Tailor-Made Course
We also offer tailor-made courses based on your needs.
Key Notes
a. The participant must be conversant with English.
b. Upon completion of training the participant will be issued with an Authorized Training Certificate
c. Course duration is flexible and the contents can be modified to fit any number of days.
d. The course fee includes facilitation training materials, 2 coffee breaks, buffet lunch and A Certificate upon successful completion of Training.
e. One-year post-training support Consultation and Coaching provided after the course.
f. Payment should be done at least a week before commence of the training, to FINESKILL TRAINING CENTER account, as indicated in the invoice so as to enable us prepare better for you.